Experiment 922828
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ROUTE NOT GIVEN |
| Organism | Empty organism |
| Citation | O'DWYER,PJ: KING,SA: HOTH,DF: SUFFNESS,M: LEYLAND-JONES,B:. (1986). HOMOHARRINGTONINE. PRESPECTIVES ON AN ACTIVE NEW NATURAL PRODUCT.. 4(10) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN PHASE 1 TRIALS, DOSE-LIMITING EFFECTS WERE HYPOTENSION AND TACHYCARDIA. OTHER TOXICITIES INCLUDED NAUSEA, VOMITING, SKIN TOXICITY AND ELEVATED LIVER ENZYMES. RARE TOXICITIES INCLUDED SERUM CREATININE ELEVATION AND HYPERGLYCEMIA. |
| Dose amount | 3.0 MG |
| Number | 15 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |